Adjuvanted RSVPreF3 Vaccine Could Prevent RSV Infection Among Older Adults
The adjuvanted RSVPreF3 vaccine could prevent nearly 3 million symptomatic RSV-ARI cases among US older adults over 3 years’ time, according to study results.
The adjuvanted RSVPreF3 vaccine could prevent nearly 3 million symptomatic RSV-ARI cases among US older adults over 3 years’ time, according to study results.
Internet Citation: National Action Alliance: Webinars. Content last reviewed April 2024. Agency for Healthcare Research and Quality, Rockville, MD. https://www.ahrq.gov/action-alliance/webinars/index.html
TeamSTEPPS is an evidence-based set of teamwork tools, aimed at optimizing patient outcomes by improving communication and teamwork skills among health care professionals. The training…
Internet Citation: National Action Alliance: Webinars. Content last reviewed April 2024. Agency for Healthcare Research and Quality, Rockville, MD. https://www.ahrq.gov/action-alliance/webinars/index.html
Women patients experience medical gaslighting wherein clinicians, policy makers, or the public do not believe their lived experiences. This article details more than 400 accounts…
Adverse drug events (ADE) are common in older adults. This systematic review identified 12 trigger tools for detecting ADE in older adults. Trigger tools designed…
Internet Citation: National Action Alliance: Webinars. Content last reviewed April 2024. Agency for Healthcare Research and Quality, Rockville, MD. https://www.ahrq.gov/action-alliance/webinars/index.html
TeamSTEPPS is an evidence-based set of teamwork tools, aimed at optimizing patient outcomes by improving communication and teamwork skills among health care professionals. The training…
Large language models (LLM) are being developed to improve diagnostic accuracy. This study compared five LLMs on their accuracy of oncology diagnoses. Accuracy ranged from…
This is the first approval of an EB virus-related mRNA therapeutic cancer vaccine and is a landmark achievement in future research on cancer treatment.
Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society…